Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGC | AZN | AMGN | GILD | BMY |
| Company | Regencell Bioscience Holdings Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 25.91 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 25.91 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 24.18 | 195.84 | 364.18 | 143.35 | 60.26 |
| Latest | 24.37 | 196.07 | 363.53 | 144.18 | 60.50 |
| Change | -1.08 | -5.46 | -15.74 | -4.04 | -1.83 |
| % Change | -4.24% | -2.71% | -4.15% | -2.73% | -2.94% |
| Volume | 35,610 | 1,504,599 | 1,069,439 | 1,962,631 | 5,289,221 |
| 20-Day Average Volume | 115,494 | 2,375,229 | 2,732,224 | 7,594,555 | 13,417,799 |
| Previous Close | 25.45 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.58 | 202.02 | 376.00 | 150.05 | 60.95 |
| 20-Day Raw Stochastic | 15.74% | 37.20% | 16.67% | 4.44% | 55.05% |
| 20-Day Relative Strength | 46.20 | 50.15 | 52.02 | 51.46 | 57.56 |
| Weighted Alpha | +52.94 | +32.96 | +21.15 | +30.39 | +13.20 |
| Today's Opinion | 40% Buy | 88% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 40% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 80% Buy | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.38% since 02/26/26 | -3.77% since 02/26/26 | -3.50% since 02/26/26 | -0.03% since 02/26/26 | -0.67% since 02/26/26 |
| Low | 22.23 on 03/03/26 | 195.84 on 03/05/26 | 364.18 on 03/05/26 | 143.36 on 03/05/26 | 60.26 on 03/05/26 |
| High | 26.85 on 03/02/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | -2.87% since 02/05/26 | +4.88% since 02/05/26 | -0.48% since 02/05/26 | -3.78% since 02/05/26 | +1.97% since 02/05/26 |
| Low | 22.23 on 03/03/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 35.70 on 02/13/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +49.94% since 12/05/25 | +8.84% since 12/05/25 | +10.96% since 12/05/25 | +18.56% since 12/05/25 | +16.38% since 12/05/25 |
| Low | 15.73 on 12/08/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 69.00 on 01/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +83.63% since 09/05/25 | +20.13% since 09/05/25 | +29.05% since 09/05/25 | +24.92% since 09/05/25 | +28.74% since 09/05/25 |
| Low | 10.33 on 11/25/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 69.00 on 01/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,584,746 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 494,489 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -3,580,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.08 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/30/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | 02/15/18 | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |